Amyotrophic Lateral Sclerosis Treatment Market to hit USD 1.1 billion by 2032, says Global Market Insights Inc.
| ETIHX Fund | USD 36.82 0.59 1.63% |
Slightly above 53% of Eventide Healthcare's investors are presently thinking to get in. The analysis of overall sentiment of trading Eventide Healthcare Life mutual fund suggests that some investors are interested at this time. Eventide Healthcare's investing sentiment can be driven by a variety of factors including economic data, Eventide Healthcare's earnings reports, geopolitical events, and overall market trends.
Eventide |
Amyotrophic lateral sclerosis treatment industry is projected to witness a CAGR of 5.5 percent during the period 2024-2032. This growth can be attributed to the development of novel drug therapies.Selbyville, Delaware, Oct. 24, 2024 -- Amyotrophic Lateral Sclerosis Treatment Market size was valued at USD 713.3 million in 2023 and is expected to grow at a CAGR of 5.5 percent from 2024 to 2032. This growth is driven by the increasing prevalence of ALS, growing awareness about the conditio
Read at finance.yahoo.com
 |
Eventide Healthcare Fundamental Analysis
We analyze Eventide Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eventide Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eventide Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
One Year Return
One Year Return Comparative Analysis
Eventide Healthcare is currently under evaluation in one year return among similar funds. One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
Eventide Healthcare Life Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eventide Healthcare mutual fund to make a market-neutral strategy. Peer analysis of Eventide Healthcare could also be used in its relative valuation, which is a method of valuing Eventide Healthcare by comparing valuation metrics with similar companies.
Peers
Eventide Healthcare Related Equities
| FBTCX | Fidelity Advisor | 0.83 | ||||
| FAFCX | Fidelity Advisor | 0.06 | ||||
| FNRCX | Fidelity Advisor | 0.14 | ||||
| FUGCX | Fidelity Advisor | 0.15 | ||||
| FTHCX | Fidelity Advisor | 1.15 |
Other Information on Investing in Eventide Mutual Fund
Eventide Healthcare financial ratios help investors to determine whether Eventide Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eventide with respect to the benefits of owning Eventide Healthcare security.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |